BridgeBio Pharma, Inc. (BBIO) — Business segments and KPIs
Revenue by business segment and geography for BridgeBio Pharma, Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Product | 362.37M | 72.2% |
| License and Service | 128.32M | 25.6% |
| Royalty | 11.39M | 2.3% |